Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V

M. Nijhuis; A.M.J. Wensing; W.F.W. Bierman; D. de Jong; R. Kagan; A. Fun; C.A.J.J. Jaspers; K.A.M. Schurink; M.A. van Agtmael; C.A.B. Boucher

doi:https://doi.org/10.1086/605329

Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V

M. Nijhuis, A.M.J. Wensing, W.F.W. Bierman, D. de Jong, R. Kagan, A. Fun, C.A.J.J. Jaspers, K.A.M. Schurink, M.A. van Agtmael, C.A.B. Boucher

Internal Medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	698-709
Journal	Journal of infectious diseases
Volume	200
Issue number	5
DOIs	https://doi.org/10.1086/605329
Publication status	Published - 2009

Access to Document

https://doi.org/10.1086/605329

http://jid.oxfordjournals.org/content/200/5/698.full.pdf+html?sid=12e9d5ae-078d-4ff7-a8f9-581b5f2617e4

Cite this

Nijhuis, M., Wensing, A. M. J., Bierman, W. F. W., de Jong, D., Kagan, R., Fun, A., Jaspers, C. A. J. J., Schurink, K. A. M., van Agtmael, M. A., & Boucher, C. A. B. (2009). Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V. Journal of infectious diseases, 200(5), 698-709. https://doi.org/10.1086/605329

@article{c58848ab9b48417f8de6d737277d48d1,

title = "Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V",

author = "M. Nijhuis and A.M.J. Wensing and W.F.W. Bierman and {de Jong}, D. and R. Kagan and A. Fun and C.A.J.J. Jaspers and K.A.M. Schurink and {van Agtmael}, M.A. and C.A.B. Boucher",

year = "2009",

doi = "https://doi.org/10.1086/605329",

language = "Undefined/Unknown",

volume = "200",

pages = "698--709",

journal = "Journal of infectious diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "5",

}

Nijhuis, M, Wensing, AMJ, Bierman, WFW, de Jong, D, Kagan, R, Fun, A, Jaspers, CAJJ, Schurink, KAM, van Agtmael, MA & Boucher, CAB 2009, 'Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V', Journal of infectious diseases, vol. 200, no. 5, pp. 698-709. https://doi.org/10.1086/605329

TY - JOUR

T1 - Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V

AU - Nijhuis, M.

AU - Wensing, A.M.J.

AU - Bierman, W.F.W.

AU - de Jong, D.

AU - Kagan, R.

AU - Fun, A.

AU - Jaspers, C.A.J.J.

AU - Schurink, K.A.M.

AU - van Agtmael, M.A.

AU - Boucher, C.A.B.

PY - 2009

Y1 - 2009

U2 - https://doi.org/10.1086/605329

DO - https://doi.org/10.1086/605329

M3 - Article

C2 - 19627247

SN - 0022-1899

VL - 200

SP - 698

EP - 709

JO - Journal of infectious diseases

JF - Journal of infectious diseases

IS - 5

ER -